Nmol/kg Range (Historical): Some early studies used 25 nmol/kg body weight, translating to approximately 2 mg for an 80 kg subject much higher dose than currently reported in wellness protocols
MOTS-C is preferred for mitochondrial and metabolic research
Its cost may limit access to a small group of patients
The impact is simple but powerful: not just weight loss, but sustainable results, stronger bodies and confidence that carries into every part of life
Novo Nordisk is focused on driving change for people living with obesity and is looking for new and innovative ways to connect more patients with the authentic medicines they are seeking and deserve, like Wegovy
What these findings suggest is that, while weight-loss drugs lead to faster results than diet and exercise alone, quitting them also results in weight being regained much faster, regardless of how much was initially lost